Cargando…
Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis
BACKGROUND: Hepatic epithelioid hemangioendothelioma (HEH) is a rare tumor type. No effective medicine or standard treatment for HEH has been established. PATIENTS AND METHODS: From March 2014 to April 2021, 62 patients with pathologically diagnosed HEH were observed regularly, and interferon-alpha...
Autores principales: | Liu, Xiaolei, Zhang, Zihuan, Huang, Jia, Tan, Haidong, Yang, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572744/ https://www.ncbi.nlm.nih.gov/pubmed/34764690 http://dx.doi.org/10.2147/CMAR.S334171 |
Ejemplares similares
-
MRI appearances of hepatic epithelioid hemangioendothelioma: a retrospective study of 57 patients
por: Liu, Xiaolei, et al.
Publicado: (2022) -
Sirolimus combined with interferon-alpha 2b therapy for giant hepatic epithelioid hemangioendothelioma: a case report
por: Liu, Xiaolei, et al.
Publicado: (2022) -
Case report: Successful treatment with the combined therapy of interferon-alpha 2b and anlotinib in a patient with advanced hepatic epithelioid hemangioendothelioma
por: Liu, Xiaolei, et al.
Publicado: (2022) -
CT appearances and classification of hepatic epithelioid hemangioendothelioma
por: Tan, Haidong, et al.
Publicado: (2023) -
Hepatic epithelioid hemangioendothelioma: is it actually “indolent”?
por: Yang, Alexander H., et al.
Publicado: (2023)